Social Determinants of Health and Their Impact on Survival and Disease Progression in Patients with Brain Tumors at Shahid Bahonar Teaching Hospital in 2019

Today, one of the primary concerns of health policymakers is social justice, which, unlike in the past, is no longer solely focused on providing healthcare services in medical centers. In this regard, the World Health Organization has introduced a framework titled Determinants of Health, aiming to promote the fair distribution of health across countries (1). Social factors that influence health are considered an intersectoral issue, referring to the conditions in which an individual is born and raised. These factors can contribute to the development of diseases or influence the severity and progression of existing conditions (2, 3). Inequalities in income, nutrition, education, housing, occupation, exposure to violence, and stress are among the most influential social determinants of health (4).

One of the diseases significantly affected by social factors is cancer (5). Cancer is a general term for a large group of diseases characterized by the uncontrolled growth of cells beyond their usual boundaries. It can invade neighboring tissues, spread to other organs, and affect almost any part of the body. Cancer has numerous anatomical and molecular subtypes, each requiring specific management strategies. In 2018, approximately 9.6 million people worldwide lost their lives to cancer (6). Cancer impacts all aspects of life, including cultural, economic, physical, mental, and social factors (7).

According to World Health Organization statistics, approximately 53,500 people died from cancer in Iran in 2011 (8). In the past, developed countries had a higher prevalence of various cancers; however, in recent years, 56% of new cancer cases and related deaths have been reported in developing countries (9).

Although cancer currently has a lower prevalence in Iran compared to some other diseases, the pattern of cancer occurrence in the country is expected to change as the population's age distribution shifts in the coming years (10). Approximately 70% of all cancer-related deaths occur in developing countries, and by 2020, this number was expected to exceed 15 million deaths annually (11, 12). Based on recent medical statistics, cancer is one of the most significant diseases of the present century and ranks as the third leading cause of death worldwide, accounting for approximately 12% of all deaths (11, 13).

Reports indicate that there are approximately 80 different types of cancer based on the location and type of affected cells. Various factors have been identified as contributing to the development of different types of cancer, and distinct social environments may have varying effects on cancer incidence (14). The most common cancers worldwide include colorectal, lung, breast, and prostate cancers (9, 15).

Social determinants of health influence a wide range of health outcomes and contribute to the development of diseases such as cardiovascular problems, diabetes, and cancer. Moreover, evidence on cancer incidence and related mortality suggests that social factors significantly affect both the occurrence and progression of the disease (16).

Given that limited studies have examined the relationship between social determinants of health and brain tumors in Iran, this research aims to analyze the relationship between social determinants of health and the survival rate of brain tumor patients in a selected hospital affiliated with Kerman University of Medical Sciences in 2019.

This cross-sectional analytical study aimed to investigate the factors affecting the survival and prognosis of patients with brain tumors at Shahid Bahonar Hospital, Kerman, in 2019. The statistical population included all patients with brain tumors who were referred to this hospital during the study period. Inclusion criteria required that patients have a confirmed brain tumor diagnosis based on medical records and pathology reports. Patients with incomplete information or those who could not be followed up for any reason were excluded from the study. A census sampling method was used, and all eligible patients (363 patients) were included in the study.

Data were collected from patients' medical records, face-to-face interviews, and medical history reviews. The variables collected included age, gender, marital status, place of residence, level of education, employment status, number of family members, type of treatment (surgery, chemotherapy, radiotherapy, or combination), and duration of follow-up. The data collection tool was a standard checklist designed based on the study variables.

Data analysis was performed using SPSS version 26 software. Descriptive statistics, including mean and standard deviation for quantitative variables and frequency and percentage for qualitative variables, were used. For survival analysis, the Kaplan-Meier test was applied to examine the relationship between demographic, social, and treatment variables. To identify factors affecting survival, the Cox regression model was used, with a statistical significance level set at P < 0.05.

This study was conducted with the approval of the Ethics Committee of Kerman University of Medical Sciences (ethics approval code: IR.KMU.REC.1399.260). Informed consent was obtained from all patients or their families, and all information was stored and analyzed with complete confidentiality. The methodology, including the precise definition of variables, standardized data collection tools, and the use of advanced statistical methods, ensured high validity and reproducibility of the study.

In the present study, 363 patients with brain tumors who were treated at Shahid Bahonar Hospital, Kerman, in 2019 were analyzed. According to the information in Table 1, the mean age of the patients was 45.6 years, with the largest age distribution observed in the 46 - 60 age group (32.5%). Among the patients, 53.7% were male and 46.3% were female. The occupational status analysis showed that 56.5% of the patients were employed, while 43.5% were unemployed. Additionally, 69.4% of the patients lived in urban areas, while 30.6% resided in rural areas. Marital status data indicated that 76.3% of the patients were married and 23.7% were single.

Regarding education level, 13.5% of the patients were illiterate, 45% had a high school education, and 41.5% had a diploma or higher. In terms of treatment, 73.3% of patients underwent surgery combined with chemotherapy and radiotherapy, while 26.7% received only one type of treatment. Analysis of family size showed that four-member families were the most common (31.4%).

Statistical analyses were conducted to identify the association between socioeconomic factors and the survival of patients with brain tumors. The Kaplan-Meier test revealed that education, employment status, number of family members, type of treatment, and place of residence had a significant effect on survival, whereas gender and marital status showed no significant association with patient survival.

Patients with a high school education or higher had a longer survival time compared to illiterate patients. The median survival for illiterate patients was 8 months, whereas this increased to 14 months for patients with a high school education or higher (P < 0.001).

Employed patients had significantly longer survival than unemployed patients. The median survival of employed patients was 15 months, while for unemployed patients, it was 10 months (P = 0.006).

Patients living in smaller families (1 - 2 members) had a longer median survival of 16 months compared to those in larger families (more than 5 members), who had a median survival of 9 months (P = 0.003).

Patients receiving combination therapy (surgery, chemotherapy, and radiotherapy) exhibited better survival outcomes than those receiving only one type of therapy. The median survival for patients in the combination therapy group was 18 months, whereas for the single therapy group, it was 8 months (P < 0.001).

Patients living in urban areas had longer survival compared to rural patients. The median survival for urban patients was 14 months, while for rural patients, it was 9 months (P = 0.02).

No significant differences were observed in median survival based on gender (P = 0.45) or marital status (P = 0.28) (Table 2).

The relationship between socio-economic status and health outcomes has been extensively studied, with growing evidence indicating that individuals from different socio-economic backgrounds experience disparities in various health conditions. While the impact of socio-economic status on chronic diseases such as heart disease, diabetes, and cancer has been widely investigated, the specific association between socio-economic status and brain tumors remains an area of exploration. Understanding this relationship is crucial for identifying potential underlying mechanisms and developing targeted interventions. This discussion aims to examine the influence of socio-economic status on the development, diagnosis, treatment, and outcomes of brain tumors.